Amedisys ROA 2010-2025 | AMED

Current and historical return on assets (ROA) values for Amedisys (AMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Amedisys ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.09B $2.19B 4.20%
2024-12-31 $0.04B $2.14B 2.03%
2024-09-30 $0.08B $2.14B 3.90%
2024-06-30 $0.09B $2.12B 4.39%
2024-03-31 $-0.02B $2.09B -1.03%
2023-12-31 $-0.01B $2.06B -0.50%
2023-09-30 $0.00B $2.03B 0.15%
2023-06-30 $0.00B $1.98B 0.15%
2023-03-31 $0.11B $1.95B 5.72%
2022-12-31 $0.12B $1.98B 6.10%
2022-09-30 $0.12B $1.98B 6.30%
2022-06-30 $0.14B $2.00B 7.32%
2022-03-31 $0.19B $1.91B 10.46%
2021-12-31 $0.21B $1.86B 12.00%
2021-09-30 $0.22B $1.94B 13.18%
2021-06-30 $0.25B $1.60B 15.58%
2021-03-31 $0.20B $1.57B 12.65%
2020-12-31 $0.18B $1.57B 11.77%
2020-09-30 $0.17B $1.60B 11.23%
2020-06-30 $0.13B $1.65B 9.28%
2020-03-31 $0.13B $1.44B 10.00%
2019-12-31 $0.13B $1.26B 10.44%
2019-09-30 $0.13B $1.21B 11.67%
2019-06-30 $0.12B $1.21B 12.84%
2019-03-31 $0.12B $1.18B 14.44%
2018-12-31 $0.12B $0.72B 15.54%
2018-09-30 $0.09B $0.73B 11.10%
2018-06-30 $0.07B $0.75B 8.85%
2018-03-31 $0.04B $0.84B 5.15%
2017-12-31 $0.03B $0.81B 3.78%
2017-09-30 $0.04B $0.80B 5.55%
2017-06-30 $0.04B $0.81B 5.17%
2017-03-31 $0.05B $0.76B 6.29%
2016-12-31 $0.04B $0.73B 5.15%
2016-09-30 $0.04B $0.72B 5.81%
2016-06-30 $0.04B $0.71B 5.50%
2016-03-31 $0.04B $0.71B 5.63%
2015-12-31 $0.00B $0.68B -0.46%
2015-09-30 $-0.01B $0.67B -1.08%
2015-06-30 $-0.01B $0.65B -1.07%
2015-03-31 $-0.01B $0.62B -1.49%
2014-12-31 $0.01B $0.67B 1.86%
2014-09-30 $-0.01B $0.68B -0.84%
2014-06-30 $-0.11B $0.71B -14.39%
2014-03-31 $-0.11B $0.73B -15.27%
2013-12-31 $-0.10B $0.73B -13.27%
2013-09-30 $-0.19B $0.76B -26.64%
2013-06-30 $-0.09B $0.70B -12.19%
2013-03-31 $-0.09B $0.71B -10.83%
2012-12-31 $-0.08B $0.73B -10.12%
2012-09-30 $0.03B $0.88B 3.13%
2012-06-30 $-0.41B $0.86B -47.63%
2012-03-31 $-0.39B $0.86B -40.30%
2011-12-31 $-0.38B $0.86B -35.03%
2011-09-30 $-0.37B $0.85B -30.32%
2011-06-30 $0.08B $1.34B 6.19%
2011-03-31 $0.09B $1.33B 7.05%
2010-12-31 $0.11B $1.30B 8.94%
2010-09-30 $0.13B $1.26B 10.47%
2010-06-30 $0.14B $1.27B 11.93%
2010-03-31 $0.15B $1.22B 12.67%
2009-12-31 $0.14B $1.17B 12.16%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.105B $2.348B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.868B 19.58
Encompass Health (EHC) United States $12.183B 25.83
DaVita (DVA) United States $10.978B 15.44
Chemed (CHE) United States $8.483B 26.66
Elanco Animal Health (ELAN) United States $6.417B 13.74
Option Care Health (OPCH) United States $5.441B 24.25
RadNet (RDNT) United States $4.587B 291.14
LifeStance Health (LFST) United States $2.271B 0.00
Addus HomeCare (ADUS) United States $2.054B 22.55
Astrana Health (ASTH) United States $1.524B 37.75
U.S Physical Therapy (USPH) United States $1.213B 31.31
Aveanna Healthcare Holdings (AVAH) United States $1.169B 66.56
Pennant (PNTG) United States $1.042B 38.25
Atai Life Sciences (ATAI) Germany $0.331B 0.00
Daxor (DXR) United States $0.037B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00